SCHEMBL4853227

SCHEMBL4853227

Cc1ccc(-c2ccn3c(=O)n(S(=O)(=O)Cc4ccc(C(F)(F)F)nc4)nc3c2Cl)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNR1 P21554 10/20 0.39
CYP2C9 P11712 4/20 0.39
CYP3A4 P08684 3/20 0.39
CYP2C19 P33261 2/20 0.39
USP1 O94782 2/20 0.34
NR3C1 P04150 2/20 0.33
GRM2 Q14416 1/20 0.33
MAPT P10636 1/20 0.33
PTGS2 P35354 4/20 0.32
PTGES O14684 1/20 0.32
HDAC3 O15379 1/20 0.32
PDPK1 O15530 1/20 0.32
CA12 O43570 1/20 0.32
PDE5A O76074 1/20 0.32
ABCB11 O95342 1/20 0.32
MT-CO2 P00403 1/20 0.32
CA1 P00915 1/20 0.32
CA2 P00918 1/20 0.32
LMNA P02545 1/20 0.32
CA3 P07451 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4491828 0.84 CNR1 (0.52) CNR1CYP2C9CYP3A4CYP2C19NR3C1
SCHEMBL4868160 0.84 CNR1 (0.44) CNR1CYP2C9CYP3A4CYP2C19NR3C1
SCHEMBL4485823 0.74 CNR1 (0.62) CNR1CYP2C9CYP3A4CYP2C19NR3C1
SCHEMBL4484236 0.73 HDAC3 (0.41) CNR1NR3C1MAPTHDAC3LMNA
SCHEMBL4798338 0.71 CNR1 (0.66) CNR1CYP2C9CYP3A4CYP2C19NR3C1
SCHEMBL4477029 0.68 CNR1 (0.67) CNR1CYP2C9CYP3A4CYP2C19NR3C1
SCHEMBL4469688 0.67 CNR1 (0.59) CNR1CYP2C9CYP3A4CYP2C19NR3C1
SCHEMBL4472953 0.65 CNR1 (0.60) CNR1CYP2C9CYP3A4CYP2C19NR3C1
SCHEMBL14212433 0.65 CNR1 (0.84) CNR1CYP2C9CYP3A4CYP2C19NR3C1
SCHEMBL4492938 0.65 CNR1 (0.75) CNR1CYP2C9CYP3A4CYP2C19NR3C1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1891068-A1 TRIAZOLOPYRIDINE DERIVATIVES AS CANNABINOID RECEPTOR 1 ANTAGONISTS Bristol-Myers Squibb Company (US) 2008-02-27 EP disclosed
WO-2006138695-A1 TRIAZOLOPYRIDINE DERIVATIVES AS CANNABINOID RECEPTOR 1 ANTAGONISTS BRISTOL-MYERS SQUIBB COMPANY (US) 2006-12-28 WO disclosed